Search PubMed⌕ Search

Biomedical subjects

M Masuno

Publications and source records attributed to M Masuno.

98 records · Page 6Linked to original sources

Restriction fragment length polymorphism analysis in healthy Japanese individuals and Japanese families with Gaucher disease.

We analysed the restriction fragment length polymorphism (RFLP) of 30 unrelated, healthy Japanese individuals and the members of seven Japanese families with Gaucher disease (5 Type I, 2 Type III) with the cDNA for human glucocerebrosidase, to investigate the frequency of the RFLP among healthy Japanese individuals and to determine the feasibility of the use of this probe DNA for carrier detection and prenatal diagnosis in Japanese families with Gaucher disease. In the Pvu II polymorphism, the common allele reported by Sorge et al was the rare allele for healthy Japanese individuals. The frequency of the common allele (+) in Japanese was 0.75 and the rare allele (-) was 0.25. The RFLP study was informative for carrier detection in the family in which both parents were heterozygous for the Pvu II polymorphism. Even in the family in which only one parent was heterozygous, carrier detection was feasible by combining the clinical history and the RFLP, although prenatal diagnosis was not feasible. The Kpn I polymorphism was not detected. It is necessary for precise carrier detection and prenatal diagnosis to investigate other restriction endonucleases which reveal the RFLP.

DNA↗

[Prevention of postoperative infection following cardiac catheterization in pediatric field. Study of air-borne bacteria in X-ray room and evaluation of an antibiotic used for prevention of postoperative infection].

As part of preventive measures against postoperative infection following cardiac catheterization in infants with cardiac diseases, especially falling bacteria in X-ray room was studied. Moreover, a synthetic penicillin, ticarcillin (TIPC), was used as preventive antibiotic against postoperative infections due to falling bacteria which probably contaminate the air in the X-ray examination room, and the efficacy and side effects of the drug were observed. As result, coagulase-negative Staphylococcus was detected the most, followed by Micrococcus and then by fungus. The number of these 3 organisms corresponded to 90.3% of the total number of falling bacteria detected during operation. The number of falling bacteria during operation was 5.1 times larger than that before operation. Taking into account normal flora of skin, falling bacteria present in the X-ray room and causative organisms of bacterial endocarditis, TIPC was administered to 30 cases intravenously 5 times at a dose of 30 mg/kg every 8 hours for the purpose of preventing possible postoperative infections following cardiac catheterization. The drug was effective to prevent such infections in all cases. No side effects were noted in any case, in peripheral blood and hepatic function tests and other observations.

Adolescent↗

No enhanced elimination of propranolol in patients with hyperthyroidism.

Propranolol, a widely used beta-adrenergic receptor blocking drug extracted mostly by the liver, plays an important role in the various aspects of managment of hyperthyroidism. If the elimination of this drug is enhanced in thyrotoxic patients, one may consider necessary a modification of the dosage regimien when treating patients with this dysfunction. We examined the disposition profiles of propranolol in four patients with hyperthyroidism before and after their thyroid states became euthyroid and compared them to those of the seven control subjects. The data indicated that the values (mean +/- SEM) of half-life (3.34 +/- 0.81 hr) and systemic availability estimated (28.2 +/- 3.5%) in the hyperthyroid state were comparable to those in the euthyroid state (2.98 +/- 0.32 hr and 29.2 +/- 5.1%) and these in the control subjects (3.20 +/- 0.32 hr and 29.0 +/- 4.0%). Although our observations were obtained from a small number of subjects, there appears to be no considerable difference in propranolol elimination from the plasma of hyperthyroid and euthyroid states or healthy subjects, and therefore adjustment of the dosage regimen seems unwarranted. Adjustment of propranolol therapy based on individual plasma levels might be useful in thyrotoxic patients who respond inadequately until additional data relating more precisely to propranolol disposition becomes available.

Adult↗